Cipla Limited
176Patents
136Active
176Granted
53Portfolio score
Filing activity: Dec 10, 2001 → Jul 12, 2022 · 56 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8522775B2 | Dry powder inhaler | Human Necessities | 50 | Active |
| USD590495S1 | Multidose inhaler | General | 49 | Expired |
| USD590938S1 | Multidose inhaler | General | 44 | Expired |
| US7404400B2 | Spacer device for inhaler | Human Necessities | 30 | Expired |
| US8168620B2 | Combination of azelastine and steroids | Human Necessities | 19 | Expired |
| US8464914B2 | Valve for an aerosol device | Human Necessities | 19 | Active |
| US7638627B2 | Process of preparing imatinib and imatinib prepared thereby | Human Necessities | 17 | Expired |
| USD591856S1 | Mouth piece | General | 15 | Expired |
| US8304405B2 | Combination of azelastine and ciclesonide for nasal administration | Human Necessities | 14 | Active |
| US8318709B2 | Combination of azelastine and mometasone for nasal administration | Human Necessities | 14 | Active |
| US8962601B2 | Pharmaceutical products and composition comprising specific anticholinergic agents, β-2 agonists and corticosteroids | Human Necessities | 13 | Active |
| USD646780S1 | Inhaler device | General | 11 | Expired |
| US9901585B2 | Combination of azelastine and fluticasone for nasal administration | Human Necessities | 11 | Active |
| USD631956S1 | Aerosal delivery device | General | 10 | Expired |
| US8633234B2 | Rifaximin | Emerging Cross-Sectional Technologies | 9 | Active |
| US7395821B2 | Multi-dose inhaler | Human Necessities | 9 | Expired |
| US9227990B2 | Antiviral phosphonate analogues and process for preparation thereof | Human Necessities | 9 | Active |
| US8163723B2 | Combination of azelastine and steroids | Human Necessities | 9 | Active |
| USD590057S1 | Inhaler | General | 8 | Expired |
| US8006695B2 | Inhaler | Human Necessities | 7 | Active |
| US7285669B2 | Process for preparing 2,6-diamino-4,5,6,7-tetrahydro-benzothiazole | Chemistry; Metallurgy | 7 | Expired |
| US10940274B2 | Nasal spray assembly | Human Necessities | 6 | Active |
| USD605497S1 | Cantilever | General | 6 | Expired |
| US10301282B2 | Polymorphic form X of nilotinib dihydrochloride hydrate | Chemistry; Metallurgy | 6 | Active |
| US9913853B2 | Stabilized liquid fosaprepitant formulations | Human Necessities | 5 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.